Taiho Oncology, Inc.
Kim Hart has extensive work experience in the pharmaceutical and healthcare industry. Kim is currently working at Taiho Oncology, Inc. as the Senior Director of Patient Alliances & Public Relations. Kim has been with the company since January 2023. Prior to their current role, they held the positions of Director of Patient Alliances & Public Relations, starting in July 2019, and Associate Director of Patient Alliances, starting in May 2017.
Before joining Taiho Oncology, Inc., Kim worked at Helsinn Group as the Associate Director of Patient Advocacy from March 2015 to April 2017. Kim also served as the Head of Post Registration Studies from January 2012 to March 2015.
Kim'sprevious experience includes working for Merck KGaA as the Head of Medical Publications, Oncology from May 2009 to December 2011, and for Eisai as a Senior Manager of Medical Education in 2008.
Kim began their career at MGI Pharma, Inc. as a Senior Medical Education Manager from 2005 to 2008. Kim also worked as a Senior Clinical Research Associate at Medtronic from 2003 to 2005, and a Senior CRA at 3M Pharmaceuticals from 1987 to 2003.
Kim Hart obtained a BS degree in Microbiology from the University of Minnesota. Additionally, in the year 2020, they enrolled in the Customer Experience Certificate Program Advisory Board offered by Seton Hall University's Stillman School of Business. No specific end year is provided for their education at either institution.
This person is not in the org chart
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com